D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 53 Citations 11,610 190 World Ranking 11472 National Ranking 217

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Organic chemistry

Michael Arand mainly investigates Antigen, Immunology, Biochemistry, Immune system and Epoxide Hydrolases. His Antigen research focuses on Cytotoxic T cell and how it connects with Epitope. In his research on the topic of Immunology, Tyrosinase Peptide, Signal peptide, Clinical trial, Immunization and Immunity is strongly related with Peptide.

His study on Endogenous mediator, Second messenger system, Signal transduction and Receptor is often connected to Aryl hydrocarbon receptor nuclear translocator as part of broader study in Biochemistry. His Epoxide Hydrolases study combines topics from a wide range of disciplines, such as Stereochemistry, Haloalkane dehalogenase and Epoxide. His Stereochemistry study incorporates themes from Hydrolase and Aspergillus niger.

His most cited work include:

  • Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes (692 citations)
  • A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens (662 citations)
  • Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. (412 citations)

What are the main themes of his work throughout his whole career to date?

Mak value, Documentation, German, Linguistics and Biochemistry are his primary areas of study. Mak value is the subject of his research, which falls under Hazardous substance. Among his research on Documentation, you can see a combination of other fields of science like Library science, Value and Addendum.

Epoxide hydrolase, Epoxide hydrolase 2, Enzyme, Epoxide Hydrolases and Microsomal epoxide hydrolase are the primary areas of interest in his Biochemistry study. His Epoxide hydrolase research incorporates elements of Stereochemistry and Epoxide. Michael Arand interconnects Hydrolase and Active site in the investigation of issues within Stereochemistry.

He most often published in these fields:

  • Mak value (41.97%)
  • Documentation (36.34%)
  • German (22.54%)

What were the highlights of his more recent work (between 2016-2020)?

  • Mak value (41.97%)
  • Documentation (36.34%)
  • German (22.54%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Mak value, Documentation, German, Linguistics and Library science. Mak value is integrated with Medicinal chemistry, Organic chemistry and Developmental toxicity in his study. Michael Arand incorporates a variety of subjects into his writings, including Documentation, Value and Addendum.

With his scientific publications, his incorporates both German and Political science. His study on Hazardous substance is intertwined with other disciplines of science such as Occupational exposure, Prenatal toxicity, Subacute toxicity, Toxicity and Pharmacology. Specifically, his work in Toxicity is concerned with the study of Toxicokinetics.

Between 2016 and 2020, his most popular works were:

  • Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia (30 citations)
  • Mode of action-based risk assessment of genotoxic carcinogens (16 citations)
  • Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria (11 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Organic chemistry

Michael Arand focuses on Documentation, Mak value, German, Linguistics and Library science. His Mak value research spans across into subjects like Medicinal chemistry, Propanol, Organic chemistry, Skin care and Pulp and paper industry. His Medicinal chemistry study which covers 4-tert-octylphenol that intersects with Chromatography.

The Ethylene glycol, Ether and Diethanolamine research Michael Arand does as part of his general Organic chemistry study is frequently linked to other disciplines of science, such as 2-Butoxyethanol and Triethanolamine, therefore creating a link between diverse domains of science. By researching both Linguistics and N dimethylformamide, he produces research that crosses academic boundaries. His Value research integrates issues from Nuclear chemistry, Xylene, Ethylbenzene and Cobalt, Cobalt compounds.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

Elke Jäger;Yao Tseng Chen;Jan W. Drijfhout;Julia Karbach.
Journal of Experimental Medicine (1998)

903 Citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

Elisabeth Stockert;Elke Jäger;Yao-Tseng Chen;Matthew J. Scanlan.
Journal of Experimental Medicine (1998)

886 Citations

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

Elke Jäger;Sacha Gnjatic;Yasuhiro Nagata;Elisabeth Stockert.
Proceedings of the National Academy of Sciences of the United States of America (2000)

586 Citations

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

E Jäger;Y Nagata;S Gnjatic;H Wada.
Proceedings of the National Academy of Sciences of the United States of America (2000)

516 Citations

A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms.

Michael Arand;Roland Mühlbauer;Jan Hengstler;Elke Jäger.
Analytical Biochemistry (1996)

441 Citations

Immunoselection in vivo : independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

Elke Jäger;Mark Ringhoffer;Michael Altmannsberger;Michael Arand.
International Journal of Cancer (1997)

402 Citations

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.

Elke Jäger;Mark Ringhoffer;Julia Karbach;Michael Arand.
International Journal of Cancer (1996)

395 Citations

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

Elke Jäger;Mark Ringhoffer;Hans Peter Dienes;Michael Arand.
International Journal of Cancer (1996)

377 Citations

Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

Elke Jäger;Dirk Jäger;Julia Karbach;Yao-Tseng Chen;Yao-Tseng Chen.
Journal of Experimental Medicine (2000)

339 Citations

Generation of cytotoxic T‐cell responses with synthetic melanoma‐associated peptides in vivo: Implications for tumor vaccines with melanoma‐associated antigens

Elke Jäeger;Helga Bernhard;Pedro Romero;Mark Ringhoffer.
International Journal of Cancer (1996)

322 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael Arand

Lloyd J. Old

Lloyd J. Old

Ludwig Cancer Research

Publications: 141

Bruce D. Hammock

Bruce D. Hammock

University of California, Davis

Publications: 129

Christophe Morisseau

Christophe Morisseau

University of California, Davis

Publications: 90

Yao-Tseng Chen

Yao-Tseng Chen

Cornell University

Publications: 84

Jan G. Hengstler

Jan G. Hengstler

TU Dortmund University

Publications: 79

Sacha Gnjatic

Sacha Gnjatic

Icahn School of Medicine at Mount Sinai

Publications: 75

Manfred T. Reetz

Manfred T. Reetz

Max Planck Society

Publications: 70

Alexander Knuth

Alexander Knuth

University of Zurich

Publications: 64

Gerd Ritter

Gerd Ritter

Memorial Sloan Kettering Cancer Center

Publications: 56

Achim A. Jungbluth

Achim A. Jungbluth

Memorial Sloan Kettering Cancer Center

Publications: 55

Daniel E. Speiser

Daniel E. Speiser

University of Lausanne

Publications: 43

Jonathan Cebon

Jonathan Cebon

La Trobe University

Publications: 43

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 42

Jean-Charles Cerottini

Jean-Charles Cerottini

University of Lausanne

Publications: 40

Pedro Romero

Pedro Romero

University of Lausanne

Publications: 38

Franz Oesch

Franz Oesch

Johannes Gutenberg University of Mainz

Publications: 37

Trending Scientists

Sanguthevar Rajasekaran

Sanguthevar Rajasekaran

University of Connecticut

Mark A. Turnquist

Mark A. Turnquist

Cornell University

Ronald Martinez

Ronald Martinez

Yahoo (United Kingdom)

Ken Takaki

Ken Takaki

Kyushu University

Tsuyohiko Fujigaya

Tsuyohiko Fujigaya

Kyushu University

Bansi D. Malhotra

Bansi D. Malhotra

Delhi Technological University

Yong-Chun Luo

Yong-Chun Luo

Lanzhou University of Technology

Theron S. Rumsey

Theron S. Rumsey

United States Department of Agriculture

Bruce D. Gossen

Bruce D. Gossen

Agriculture and Agriculture-Food Canada

Colin D. McCaig

Colin D. McCaig

University of Aberdeen

Fred Beisson

Fred Beisson

Aix-Marseille University

Bon-Kyoung Koo

Bon-Kyoung Koo

Austrian Academy of Sciences

G. R. Gladstone

G. R. Gladstone

Southwest Research Institute

Christian S. Crandall

Christian S. Crandall

University of Kansas

Jukka S. Jurvelin

Jukka S. Jurvelin

University of Eastern Finland

Bernhard R. Brandl

Bernhard R. Brandl

Leiden University

Something went wrong. Please try again later.